Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: A double-blind, placebo-controlled multicenter study

Chest

Volumn 122, Issue 6, 2002, Pages 2042-2049

  Schaad, Urs B ^a   Mütterlein, Ralph ^b   Goffin, Heidi ^c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Regional Hospital of Parsberg   (Germany)

^c Vifor (International) Inc   (Switzerland)

Author keywords

Bacterial extract; Child; Immunostimulation; OM 85; Prevention; Recurrence; Upper respiratory tract infection

Indexed keywords

BACTERIUM LYSATE; PLACEBO;

ARTICLE; CAPSULE FILLING; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTHERMIA; IMMUNOSTIMULATION; LARYNX DISORDER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; RHINITIS; RISK FACTOR; UPPER RESPIRATORY TRACT INFECTION;

EID: 0036928674     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.6.2042     Document Type: Article

References (24)

1. World Health Organization. Acute respiratory infections: The forgotten pandemic. Bull World Health Organ 1998; 76:101-103
2. Collet JP, Burtin P, Floret D. Risque infectieux chez l'enfant en crèche. Rev Prat 1992; 42:1797-1803
3. Williams BG, Gouws E, Boschi-Pinto C, et al. Estimates of worldwide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2002; 2:25-32
4. Eggenberger K. Les infections des voies respiratoires les plus fréquentes chez l'enfant dans la pratique ambulatoire. Ars Medici 1993; 83(suppl):24-40
5. Cohen R. Enquête nationale sur les critères de prescription d'une antibiothérapie dans les rhinopharyngites en pédiatrie en ville. Ann Pédiatr (Paris) 1992; 39:195-201
6. Stickler GB, Smith TF, Broughton DD. The common cold. Eur J Pediatr 1985; 144:4-8
7. De Baets F, Kint J, Pauwels R, et al. IgG subclass deficiency in children with recurrent bronchitis. Eur J Pediatr 1992; 151:274-278
8. David JR, Rosen FS. Deficiencies in Immunoglobulins and Cell-Mediated Immunity [CD-ROM]. Chapter IX. Scientific American Medicine (New York, NY), SAM-CD, 2000
9. Mauel J. Stimulation of immunoprotective mechanisms by OM-85 BV: A review of results from in vivo and in vitro studies. Respiration 1994; 61(suppl 1):8-15
10. Puigdollers JM, Serna GR, Hernandez del Rey I, et al. Immunoglobulin production in man stimulated by an orally administered bacterial lysate. Respiration 1980; 40:142-149
11. Emmerich B, Emslander HP, Milatovic D, et al. Effects of a bacterial extract on local immunity of the lung in patients with chronic bronchitis. Lung 1990; 168:726-731
12. Lusuardi M, Capelli A, Carli S, et al. Local airways immune modifications induced by oral bacterial extracts in chronic bronchitis. Chest 1993; 103:1783-1791
13. Tielemans C, Gastadello K, Husson C, et al. Efficacy of oral immunotherapy on respiratory infections in hemodialysis patients: A double-blind, placebo-controlled study. Clin Nephrol 1999; 51:153-160
14. Orcel B, Delclaux B, Baud M, et al. Oral immunisation with bacterial extracts for protection against acute bronchitis in elderly, institutionalised patients with chronic bronchitis. Eur Respir J 1994; 7:446-452
15. Heintz B, Schlenter WW, Kirsten R, et al. Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitis: A multicentric, placebo-controlled, double-blind study. Int J Clin Pharmacol Ther Toxicol 1989; 27:530-534
16. Collet JP, Shapiro P, Ernst P, et al. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156:1719-1724
17. Collet JP, Ducruet T, Kramer MS, et al. Stimulation of non-specific immunity to reduce the risk of recurrent infections in children attending day-care centers. Pediatr Infect Dis J 1993; 12:648-652
18. Paupe J. Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections. Respiration 1991; 58:150-154
19. Zagar S, Löfler-Badzek D. Broncho-Vaxom in children with rhinosinusitis: A double-blind clinical trial. ORL J Otorhinolaryngol Relat Spec 1988; 50:397-404
20. Aymard M, Chomel JJ, Allard JP, et al. Epidemiology of viral infections and evaluation of the potential benefit of OM-85 BV on the virologic status of children attending day-care centers. Respiration 1994; 61 (suppl 1):24-31
21. Jara-Pérez J, Berber A. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: A double-masked, placebo-controlled clinical trial. Clin Ther 2000; 22:748-759
22. Gutiérrez-Tarango MD, Berber A. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months. Chest 2001; 119:1742-1748
23. Machin D, Campbell M. Statistical Tables for the Design of Clinical Trials. Blackwell Scientific Publications (Oxford, UK) 1987; 18-33
24. Schaad UB, Farine JC, Fux T. Prospektive Plazebo-kontrollierte doppelblindstudie mit einem bakterienlysat bei infektionen der atemwege und des ORL-bereiches im kindesalter. Helv Paediatr Acta 1986; 41:7-17